Bumetanide Injection
Fresenius Kabi USA, LLC
Open FDA's page for this record- Update type
- Revised
- Initial posting date
- 01/31/2018
- Change date
- 09/30/2026
- Package NDC
- 65219-572-10
- Generic name
- Bumetanide Injection
- Contact info
- 888-386-1300
- Resolved note
- Available
- Update date
- 09/30/2026
- Dosage form
- Injection
- Presentation
- Bumetanide, Injection, .25 mg/1 mL (NDC 65219-572-10)
- Company name
- Fresenius Kabi USA, LLC
- Status
- Resolved
- Therapeutic category
- Cardiovascular
- Harmonized identifiers (openFDA)
- Application number
- ANDA216434
- Brand name
- BUMETANIDE
- Generic name
- BUMETANIDE
- Manufacturer name
- Fresenius Kabi USA, LLC
- Product NDC
- 65219-572, 65219-570
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Substance name
- BUMETANIDE
- RxCUI
- 282486, 1727569
- SPL ID
- aaff61c4-203b-4905-9138-0f98959ad013
- SPL set ID
- a007f3aa-3977-4be3-a9a2-db3d458bca58
- Package NDC
- 65219-570-01, 65219-570-04, 65219-572-01, 65219-572-10
- Nui
- N0000175366, N0000175590
- Pharm class pe
- Increased Diuresis at Loop of Henle [PE]
- Pharm class epc
- Loop Diuretic [EPC]
- UNII
- 0Y2S3XUQ5H